Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Charles River Laboratories International Inc CRL

Technology Scientific & Technical Instruments
Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. The Company's Research Models and Services segment is comprised of three businesses that provide foundational tools that enables its... see more

Recent & Breaking News (NYSE:CRL)

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Charles River Laboratories International, Inc. (CRL) on Behalf of Investors

Business Wire February 22, 2023

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Charles River Laboratories International, Inc. (CRL) on Behalf of Investors

Business Wire February 22, 2023

The Law Offices of Frank R. Cruz Announces Investigation of Charles River Laboratories International, Inc. (CRL) on Behalf of Investors

Business Wire February 22, 2023

Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance

Business Wire February 22, 2023

Charles River and Flagship's Pioneering Medicines Enter Agreement Leveraging AI-Powered Logica with Aim of Creating Novel Therapies for Unmet Medical Needs

Business Wire February 16, 2023

Charles River and Purespring Therapeutics Announce Gene Therapy Manufacturing Collaboration

Business Wire February 15, 2023

Charles River Launches Novel IgY-based ELISA Kit for the Detection and Quantitation of Residual Host Cell Protein

Business Wire February 13, 2023

Charles River Laboratories Schedules Fourth-Quarter 2022 Earnings and 2023 Guidance Release and Conference Call

Business Wire February 9, 2023

Charles River Laboratories Acquires SAMDI Tech

Business Wire January 30, 2023

Charles River and Rznomics Announce RNA-based Anticancer Gene Therapy Manufacturing Alliance

Business Wire January 18, 2023

Charles River Launches CliniPrime Suite of GMP-Compliant Cellular Products

Business Wire January 16, 2023

Charles River Establishes eXpDNA(TM) Plasmid Manufacturing Platform to Expedite DNA Programs

Business Wire January 12, 2023

Charles River Laboratories to Present at J.P. Morgan Healthcare Conference

Business Wire January 9, 2023

Charles River Laboratories Adds Craig B. Thompson, M.D. to Board of Directors

Business Wire December 6, 2022

Charles River Launches Endosafe Nexus 200, Emphasizes Critical Importance of Smart Automation for Endotoxin Detection

Business Wire December 1, 2022

Charles River Laboratories Opens Contract Vivarium Space in Chicago, Enhancing Access to AAALAC-Accredited, Turnkey Research Program

Business Wire November 28, 2022

Charles River Laboratories to Present at November Investor Conferences

Business Wire November 14, 2022

Charles River Laboratories Demonstrates Excellence in Advanced Modalities at Neuroscience 2022

Business Wire November 10, 2022

Charles River Announces Cell Therapy Manufacturing Capacity Expansion, Reinforcing Commitment to CDMO Clients

Business Wire November 7, 2022

Charles River Laboratories Announces Third-Quarter 2022 Results

Business Wire November 2, 2022